WATSON 796
Pill imprint WATSON 796 has been identified as Sulfasalazine 500 mg.
Sulfasalazine is used in the treatment of ulcerative colitis; crohn's disease, maintenance; rheumatoid arthritis; alopecia; ulcerative colitis, maintenance (and more), and belongs to the drug classes 5-aminosalicylates, sulfonamides. There is no proven risk in humans during pregnancy.
Sulfasalazine 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Sulfasalazine Images
- Imprint:
-
WATSON 796
- Strength:
- 500 mg
- Color:
- Yellow
- Size:
- 13.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
pregelatinized corn starch
stearic acid
sodium starch glycolate type A potato
- Drug Class:
- 5-aminosalicylates
Sulfonamides - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0796
Advertisement
More Sulfasalazine resources
- Sulfasalazine (Wolters Kluwer)
- Sulfasalazine Delayed-Release Tablets (Wolters Kluwer)
- sulfasalazine (Cerner Multum)
- Alti-Sulfasalazine Oral, Rectal (Micromedex) - Includes Dosage Information
- Salazopyrin Oral, Rectal (Micromedex) - Includes Dosage Information
- sulfasalazine Oral, Rectal (Micromedex) - Includes Dosage Information
- Sulfasalazine (AHFS DI)
- Sulfasalazine (FDA)
- Sulfasalazine Delayed-Release Tablets (FDA)
- Sulfasalazine (Wolters Kluwer)
Search Again
